Latest Johnson & Johnson Stories
NEW BRUNSWICK, N.J., Jan. 21, 2015 /PRNewswire/ -- The Dr. Paul Janssen Award for Biomedical Research today opens its 2015 call for nominations.
Case Funding Firm reports no major news since the $1 billion Stryker settlement over their Rejuvenate and ABG II recalled hip products. HOUSTON, Jan.
Bernstein Liebhard LLP notes the filing of more than 9,000 transvaginal mesh lawsuits in two separate litigations in New Jersey, where the Firm's attorneys are actively filing claims.
MONTREAL, Jan. 19, 2015 /CNW Telbec/ - CQDM is very pleased to announce that Janssen Inc.
Consortia funded through the IMI Ebola+ Programme Supported by the European Commission NEW BRUNSWICK, N.J., Jan.
TITUSVILLE, N.J., Jan. 15, 2015 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. (JPI) today announced it has entered into a definitive agreement with Depomed, Inc. to divest its U.S.
The litigation brought over the Johnson & Johnson subsidiary’s all-metal hip device continues to proceed with an Order for an open court conference. Port
Findings Add to Rigorous Post-Marketing Safety Program for XARELTO® in Routine Clinical Practice RARITAN, N.J., Jan.
PLYMOUTH, Mich., Jan. 14, 2015 /PRNewswire/ -- Tissue Regeneration Systems, Inc.
Job board for medical sales representatives announces the best medical companies to work for in the new year Alpharetta, GA (PRWEB) January 13, 2015
- A political dynamiter.